欢迎访问东方智库
会员登录 | 免费注册
讲师入驻通道
免费咨询热线:13810808675
Andrew A. Young AndrewA.Young,ChiefScientificOfficerofIntarciaTherapeutics,Inc.,ResearchTrianglePark,NC,U.S.A.AndrewYoungreceivedhisM.B.,Ch.B.(M.D.)andhisPh.D.inPhysiologyfromtheUniversityofAuckland,NewZealand.FollowingclinicalpracticewiththeAucklandHospitalBoard,andasageneralmedicalpractitioner,hejoinedthefacultyasalecturerintheDepartmentofPhysiologyattheUniversityofAuckland.In1984hebecameaClinicalResearchScientistattheNationalInstitutesofHealthinPhoenix,Arizona,wherehestudiedinsulinresistanceanddiabetes.Fromthere,hemovedtoBadNauheim,Germany,whereasaMax-PlanckFellowhestudiedtheelectrophysiologyofpainandtemperaturesensation.In1989AndrewYoungjoinedAmylinPharmaceuticalsIncinSanDiegoasthefoundingphysiologist,becomingVicePresident,Researchin1998andasVicePresidentandSeniorResearchFellowin2002.Heleadphysiologiccharacterizationofthehormone,amylin,ananalogofwhich,pramlintide,waslaunchedasSYMLIN,afirst-in-classtreatmentforinsulin-requiringdiabetes.Hewasalsoresponsiblefortheacquisitionandpreclinicaldevelopmento
热点文章
-
02-18 / (4271)
-
02-29 / (2717)
联系我们
微信咨询
微信扫一扫